Retrovirology Journal Citation Rate 2026
1742-4690
BioMed Central
GB
Q1 Quartile Open Access Established Impact
About Retrovirology
Retrovirology (R) is a peer-reviewed academic journal covering HIV Research and Treatment and HIV/AIDS Research and Interventions, published by BioMed Central in GB, catalogued under ISSN 1742-4690. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 4.76 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $2440 USD.
Retrovirology Citation Rate 2026 — In Context
Retrovirology has a 2025 2-Year Citation Rate (OpenAlex) of 4.76, placing it in the Q1 quartile within the HIV Research and Treatment research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, Retrovirology makes all articles freely available to readers for an Article Processing Charge of approximately $2440 USD.
Researchers looking to publish in Retrovirology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Retrovirology against similar journals in the field, use our journal comparison tool.
Submission Tips for Retrovirology
- Budget $2440 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers HIV Research and Treatment, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Retrovirology Compares
Compared against 6 journals in the same research areas.
| ISSN (Print) | 1742-4690 |
|---|---|
| Publisher | BioMed Central |
| Country | United Kingdom |
| APC / Cost | $2440 USD |
In-depth profile & metrics
Retrovirology is published by BioMed Central and based in United Kingdom. It publishes open access with an article-processing charge of USD 2440.
In our subject taxonomy, Retrovirology is classified under HIV Research and Treatment, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment and Immune Cell Function and Interaction.
Retrovirology is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 4.762.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Retrovirology
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 4.762 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Retrovirology against similar publications in its field:
Related Journals in Your Field
-
Immunological Reviews Wiley IF 8.21
-
JCI Insight American Society for Clinical Investigation IF 5.03
-
Journal of Clinical Immunology Springer Science+Business Media IF 3.05
-
Current Opinion in Immunology Elsevier BV IF 2.98
-
Journal of the International AIDS Society International AIDS Society IF 2.90
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S54115554
Get weekly updates for HIV Research and Treatment journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.